These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9488964)

  • 21. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
    Krasnova TN; Shilov EM; Tareeva IE; Gordovskaia NB; Lavrova ON; Miroshnichenko NG; Troepol'skaia OV; Ivanova LV; Ivanov AA
    Ter Arkh; 1998; 70(6):14-7. PubMed ID: 9695216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL; Shkerina LI; Shilov EM
    Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microscopic polyangiitis with ocular involvement.
    Caster JC; Shetlar DJ; Pappolla MA; Yee RW
    Arch Ophthalmol; 1996 Mar; 114(3):346-8. PubMed ID: 8600899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicenter study of Consupren (cyclosporine) versus cyclophosphamide in chronic glomerulonephritis.
    Matl I; Matousovic K; Lánská V
    Transplant Proc; 1996 Dec; 28(6):3149-51. PubMed ID: 8962220
    [No Abstract]   [Full Text] [Related]  

  • 25. [Severe digestive vasculitis: value of bolus of cyclophosphamide].
    Le Thi Huong Du; Wechsler B; Grand d'Esnon A; Vignes B; Baculard A; Montagne JP; Chigot JP; Guesquière F; Polonovski C; Godeau P
    Gastroenterol Clin Biol; 1988 Apr; 12(4):402-4. PubMed ID: 3290032
    [No Abstract]   [Full Text] [Related]  

  • 26. IgA glomerulonephritis associated with microscopic polyangiitis or Churg-Strauss syndrome.
    Richer C; Mouthon L; Cohen P; Buchet P; Royer I; Guettier C; Guillevin L
    Clin Nephrol; 1999 Jul; 52(1):47-50. PubMed ID: 10442496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement.
    de Lind van Wijngaarden RA; Hauer HA; Wolterbeek R; Jayne DR; Gaskin G; Rasmussen N; Noël LH; Ferrario F; Waldherr R; Hagen EC; Bruijn JA; Bajema IM
    J Am Soc Nephrol; 2006 Aug; 17(8):2264-74. PubMed ID: 16825335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ANCA-associated vasculitis with renal involvement: an outcome analysis.
    Weidner S; Geuss S; Hafezi-Rachti S; Wonka A; Rupprecht HD
    Nephrol Dial Transplant; 2004 Jun; 19(6):1403-11. PubMed ID: 15069175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunosuppressive therapy (cytostatics) in glomerulonephritis].
    Ricken D
    Verh Dtsch Ges Inn Med; 1972; 78():766-70. PubMed ID: 4665751
    [No Abstract]   [Full Text] [Related]  

  • 30. [Microscopic polyangiitis].
    Lauque D; Pourrat J
    Rev Prat; 2000 Feb; 50(3):268-70. PubMed ID: 11923950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Our experiences in the immunosuppressive treatment of chronic glomerulonephritis].
    Labos I; Ajdar M
    Med Arh; 1976; 30(2):115-8. PubMed ID: 966827
    [No Abstract]   [Full Text] [Related]  

  • 32. [Microscopic polyangiitis].
    Venetz JP; Rossert J
    Ann Med Interne (Paris); 2000 May; 151(3):193-8. PubMed ID: 10896971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome analysis of patients with vasculitis associated with antineutrophil cytoplasmic antibodies.
    Brijker F; Magee CC; Tervaert JW; O'Neill S; Walshe JJ
    Clin Nephrol; 1999 Dec; 52(6):344-51. PubMed ID: 10604641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Membranous nephropathy and crescentic glomerulonephritis].
    Vozmediano C; Sánchez de la Nieta MD; González L; Alvarez T; de la Torre M; Blanco J; Nieto J; Rivera F
    Nefrologia; 2005; 25(3):328-31. PubMed ID: 16053015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monthly cyclophosphamide pulses in the treatment of crescentic glomerulonephritis.
    De La Torre M; Alcázar R; Urra JM; Caparrós G; Alegre R; Blanco J; Nieto J; Ferreras I
    Transplant Proc; 1998 Dec; 30(8):3952-4. PubMed ID: 9865259
    [No Abstract]   [Full Text] [Related]  

  • 36. Improved outcome in Wegener's granulomatosis and microscopic polyangiitis? A retrospective analysis of 95 cases in two cohorts.
    Eriksson P; Jacobsson L; Lindell A; Nilsson JA; Skogh T
    J Intern Med; 2009 Apr; 265(4):496-506. PubMed ID: 19141094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppression in the treatment of glomerulonephritis.
    Soothill JF; Barratt TM
    Adv Nephrol Necker Hosp; 1971; 1():75-81. PubMed ID: 5006260
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunodepressant drugs in the treatment of glomerulonephritis.
    Cameron JS
    J Ir Med Assoc; 1971 Sep; 64(419):466-7. PubMed ID: 5118862
    [No Abstract]   [Full Text] [Related]  

  • 39. Crescentic membranoproliferative glomerulonephritis and hypocomplementemic urticarial vasculitis.
    Enríquez R; Sirvent AE; Amorós F; Pérez M; Matarredona J; Reyes A
    J Nephrol; 2005; 18(3):318-22. PubMed ID: 16013022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The therapy of vasculitis].
    Andrassy K; Waldherr R; Hergesell O; Ritz E
    Dtsch Med Wochenschr; 1996 Aug; 121(31-32):985-7. PubMed ID: 8765402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.